Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Qiuping Ye, Min Jiang, Wotang T. Huang, Yun Ling, Steven H. Olson, Daqing Sun, Guifen Xu, Xuelei Yan, Bradley K. Wong & Lixia Jin. (2015) Pharmacokinetics and metabolism of AMG 232, a novel orally bioavailable inhibitor of the MDM2–p53 interaction, in rats, dogs and monkeys: in vitro–in vivo correlation. Xenobiotica 45:8, pages 681-692.
Read now
Read now
Vicki M. Richardson, Stephen S. Ferguson, Yusupha M. Sey & Michael J. DeVito. (2014) In vitro metabolism of thyroxine by rat and human hepatocytes. Xenobiotica 44:5, pages 391-403.
Read now
Read now
Qinghua Wu, Lingli Huang, Zhaoying Liu, Min Yao, Yulian Wang, Menghong Dai & Zonghui Yuan. (2011) A comparison of hepatic in vitro metabolism of T-2 toxin in rats, pigs, chickens, and carp. Xenobiotica 41:10, pages 863-873.
Read now
Read now
Brandon Swift*Nathan D. Pfeifer*Kim L.R. Brouwer. (2010) Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metabolism Reviews 42:3, pages 446-471.
Read now
Read now
R. Smith, R. D. O. Jones, P. G. Ballard & H. H. Griffiths. (2008) Determination of microsome and hepatocyte scaling factors for / extrapolation in the rat and dog. Xenobiotica 38:11, pages 1386-1398.
Read now
Read now
G. I. Somers, M. K. Bayliss & J. B. Houston. (2007) The metabolism of the 5HT3 antagonists, ondansetron, alosetron and GR87442 II: Investigation into the in vitro methods used to predict the in vivo hepatic clearance of ondansetron, alosetron and GR87442 in the rat, dog and human. Xenobiotica 37:8, pages 855-869.
Read now
Read now
Nicola J. Hewitt, María José Gómez Lechón, J. Brian Houston, David Hallifax, Hayley S. Brown, Patrick Maurel, J. Gerald Kenna, Lena Gustavsson, Christina Lohmann, Christian Skonberg, Andre Guillouzo, Gregor Tuschl, Albert P. Li, Edward LeCluyse, Geny M. M. Groothuis & Jan G. Hengstler. (2007) Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies. Drug Metabolism Reviews 39:1, pages 159-234.
Read now
Read now
D. M. CROSS & M. K. BAYLISS. (2000) A COMMENTARY ON THE USE OF HEPATOCYTES IN DRUG METABOLISM STUDIES DURING DRUG DISCOVERY AND DEVELOPMENT*. Drug Metabolism Reviews 32:2, pages 219-240.
Read now
Read now
N. J. Hewitt, T. Fischer, U. Zuehlke, F. Oesch & D. Utesch. (2000) Metabolic activity of fresh and cryopreserved cynomolgus monkey (Macaca fascicularis) hepatocytes. Xenobiotica 30:7, pages 665-681.
Read now
Read now
Articles from other publishers (49)
Paresh P. Chothe, Sean Xiaochun Zhu, Sandeepraj Pusalkar, Chuang Lu & Cindy Xia. 2023. Oral Bioavailability and Drug Delivery. Oral Bioavailability and Drug Delivery
757
778
.
Bing Qi, Matthias Gijsen, Tom De Vocht, Neel Deferm, Pieter Van Brantegem, Getahun B. Abza, Nina Nauwelaerts, Joost Wauters, Isabel Spriet & Pieter Annaert. (2023) Unravelling the Hepatic Elimination Mechanisms of Colistin. Pharmaceutical Research 40:7, pages 1723-1734.
Crossref
Crossref
Mai Shimizu, Tatsuki Fukami, Keisho Okura, Toshio Taniguchi, Yukihiro Nomura & Miki Nakajima. (2023) Utility of a Systematic Approach to Selecting Candidate Prodrugs: A case Study using Candesartan Ester Analogues. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Marothu Vamsi Krishna, Kantamaneni Padmalatha & Gorrepati Madhavi. 2021. Drug Metabolism. Drug Metabolism.
Elzbieta Izbicka & Robert T. Streeper. (2021) Azelaic Acid Esters as Pluripotent Immunomodulatory Molecules: Nutritional Supplements or Drugs. Nutraceuticals 1:1, pages 42-53.
Crossref
Crossref
Mai Shimizu, Tatsuki Fukami, Hiroyuki Ogawa, Toshio Taniguchi, Yukihiro Nomura & Miki Nakajima. (2021) Systematic Approach for Screening of Prodrugs: Evaluation Using Oseltamivir Analogues as Models. Journal of Pharmaceutical Sciences 110:2, pages 925-934.
Crossref
Crossref
Annelies Noorlander, Eric Fabian, Bennard van Ravenzwaay & Ivonne M. C. M. Rietjens. (2020) Novel testing strategy for prediction of rat biliary excretion of intravenously administered estradiol-17β glucuronide. Archives of Toxicology 95:1, pages 91-102.
Crossref
Crossref
Mitesh Patel, H. Christian Eberl, Andrea Wolf, Esaie Pierre, Joseph W. Polli & Maciej J. Zamek-Gliszczynski. (2019) Mechanistic Basis of Cabotegravir–Glucuronide Disposition in Humans. Journal of Pharmacology and Experimental Therapeutics 370:2, pages 269-277.
Crossref
Crossref
María Dolores Pizarro, María Eugenia Mamprin, Lucas Damián Daurelio, Joaquín Valentín Rodriguez & María Gabriela Mediavilla. (2018) Experimental bio-artificial liver: Importance of the architectural design on ammonia detoxification performance. World Journal of Hepatology 10:10, pages 719-730.
Crossref
Crossref
Mitesh Patel, Marta Johnson, Caroline J. Sychterz, Gareth J. Lewis, Cory Watson, Harma Ellens, Joseph W. Polli & Maciej J. Zamek-Gliszczynski. (2018) Hepatobiliary Disposition of Atovaquone: A Case of Mechanistically Unusual Biliary Clearance. Journal of Pharmacology and Experimental Therapeutics 366:1, pages 37-45.
Crossref
Crossref
Francesca L. Wood, J. Brian Houston & David Hallifax. (2018) Importance of the Unstirred Water Layer and Hepatocyte Membrane Integrity In Vitro for Quantification of Intrinsic Metabolic Clearance. Drug Metabolism and Disposition 46:3, pages 268-278.
Crossref
Crossref
F. L. Wood, J. B. Houston & D. Hallifax. (2017) Clearance Prediction Methodology Needs Fundamental Improvement: Trends Common to Rat and Human Hepatocytes/Microsomes and Implications for Experimental Methodology. Drug Metabolism and Disposition 45:11, pages 1178-1188.
Crossref
Crossref
Tom De Bruyn, Patrick F. Augustijns & Pieter P. Annaert. (2016) Hepatic Clearance Prediction of Nine Human Immunodeficiency Virus Protease Inhibitors in Rat. Journal of Pharmaceutical Sciences 105:2, pages 846-853.
Crossref
Crossref
Ujjal Sarkar, Dinelia Rivera-Burgos, Emma M. Large, David J. Hughes, Kodihalli C. Ravindra, Rachel L. Dyer, Mohammad R. Ebrahimkhani, John S. Wishnok, Linda G. Griffith & Steven R. Tannenbaum. (2015) Metabolite Profiling and Pharmacokinetic Evaluation of Hydrocortisone in a Perfused Three-Dimensional Human Liver Bioreactor. Drug Metabolism and Disposition 43:7, pages 1091-1099.
Crossref
Crossref
Raj K. Singh Badhan. 2015. Computational Pharmaceutics. Computational Pharmaceutics
263
291
.
Jean Matthieu Prot, Luis Maciel, Thibault Bricks, Franck Merlier, Jérôme Cotton, Patrick Paullier, Fréderic Yves Bois & Eric Leclerc. (2014) First pass intestinal and liver metabolism of paracetamol in a microfluidic platform coupled with a mathematical modeling as a means of evaluating ADME processes in humans. Biotechnology and Bioengineering 111:10, pages 2027-2040.
Crossref
Crossref
Joost Westerhout, Dirk-Jan van den Berg, Robin Hartman, Meindert Danhof & Elizabeth C.M. de Lange. (2014) Prediction of methotrexate CNS distribution in different species – Influence of disease conditions. European Journal of Pharmaceutical Sciences 57, pages 11-24.
Crossref
Crossref
Régis Baudoin, Giulia Alberto, Audrey Legendre, Patrick Paullier, Marie Naudot, Marie‐José Fleury, Sébastien Jacques, Laurent Griscom & Eric Leclerc. (2014) Investigation of expression and activity levels of primary rat hepatocyte detoxication genes under various flow rates and cell densities in microfluidic biochips. Biotechnology Progress 30:2, pages 401-410.
Crossref
Crossref
Erik Sjögren, Ulf Bredberg & Hans Lennernäs. (2012) The Pharmacokinetics and Hepatic Disposition of Repaglinide in Pigs: Mechanistic Modeling of Metabolism and Transport. Molecular Pharmaceutics 9:4, pages 823-841.
Crossref
Crossref
Naoki Kotani, Kazuya Maeda, Takao Watanabe, Mariko Hiramatsu, Li-kun Gong, Yi-an Bi, Toshiaki Takezawa, Hiroyuki Kusuhara & Yuichi Sugiyama. (2011) Culture Period-Dependent Changes in the Uptake of Transporter Substrates in Sandwich-Cultured Rat and Human Hepatocytes. Drug Metabolism and Disposition 39:9, pages 1503-1510.
Crossref
Crossref
Cindy Q. Xia, Chuang Lu & Suresh K. Balani. 2011. Oral Bioavailability. Oral Bioavailability
475
491
.
Tatsuyuki Kanamori, Kenji Kuwayama, Kenji Tsujikawa, Hajime Miyaguchi, Yuko Togawa-Iwata & Hiroyuki Inoue. (2011) A model system for prediction of the in vivo metabolism of designer drugs using three-dimensional culture of rat and human hepatocytes. Forensic Toxicology 29:2, pages 142-151.
Crossref
Crossref
CHUKWUEMEKA ANENE-NZELU, YAN WANG, HANRY YU & LEO HWA LIANG. (2011) LIVER TISSUE MODEL FOR DRUG TOXICITY SCREENING. Journal of Mechanics in Medicine and Biology 11:02, pages 369-390.
Crossref
Crossref
Graham F. Smith. 2011. Progress in Medicinal Chemistry Volume 50. Progress in Medicinal Chemistry Volume 50
1
47
.
Erik Sjögren, Ulf Bredberg, Erik Allard, Björn Arvidsson, Jonas Bergquist, Tommy B. Andersson & Hans Lennernäs. (2010) Hepatic Disposition of Ximelagatran and Its Metabolites in Pig; Prediction of the Impact of Membrane Transporters Through a Simple Disposition Model. Pharmaceutical Research 27:4, pages 597-607.
Crossref
Crossref
Sepuri Asha & Maravajhala Vidyavathi. (2009) Role of Human Liver Microsomes in In Vitro Metabolism of Drugs—A Review. Applied Biochemistry and Biotechnology 160:6, pages 1699-1722.
Crossref
Crossref
Urban Fagerholm. (2007) Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance. Journal of Pharmacy and Pharmacology 59:6, pages 803-828.
Crossref
Crossref
Megumi Iwai, Tsuyoshi Minematsu, Shinichi Narikawa, Takashi Usui & Hidetaka Kamimura. (2009)
Involvement of Human Organic Cation Transporter 1 in the Hepatic Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1
H
-naphtho[2,3-
d
]imidazolium Bromide (YM155 Monobromide), a Novel, Small Molecule Survivin Suppressant
. Drug Metabolism and Disposition 37:9, pages 1856-1863.
Crossref
Crossref
William J. Fasano, Lisa M. Sweeney, Michael P. Mawn, Diane L. Nabb, Bogdan Szostek, Robert C. Buck & Michael L. Gargas. (2009) Kinetics of 8-2 fluorotelomer alcohol and its metabolites, and liver glutathione status following daily oral dosing for 45 days in male and female rats. Chemico-Biological Interactions 180:2, pages 281-295.
Crossref
Crossref
Charles B. Davis, Ramesh Bambal, Ganesh S. Moorthy, Erin Hugger, Hong Xiang, Brian Kevin Park, Allison E. Shone, Paul M. O’Neill & Stephen A. Ward. (2009) Comparative preclinical drug metabolism and pharmacokinetic evaluation of novel 4-aminoquinoline anti-malarials. Journal of Pharmaceutical Sciences 98:1, pages 362-377.
Crossref
Crossref
Ahmed Kousba, Richard Soll, Shiyin Yee & Michael Martin. (2007)
Cyclic Conversion of the Novel Src Kinase Inhibitor [7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its
N
-Oxide Metabolite by Flavin-Containing Monoxygenases and Cytochrome P450 Reductase
. Drug Metabolism and Disposition 35:12, pages 2242-2251.
Crossref
Crossref
M. Dickins, A. Galetin & N. Proctor. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
827
846
.
Anna-Karin Sohlenius-Sternbeck. (2006) Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements. Toxicology in Vitro 20:8, pages 1582-1586.
Crossref
Crossref
N. Hariparsad, R.S. Sane, S.C. Strom & P.B. Desai. (2006) In vitro methods in human drug biotransformation research: Implications for cancer chemotherapy. Toxicology in Vitro 20:2, pages 135-153.
Crossref
Crossref
M.D. Tingle & N.A. Helsby. (2006) Can in vitro drug metabolism studies with human tissue replace in vivo animal studies?. Environmental Toxicology and Pharmacology 21:2, pages 184-190.
Crossref
Crossref
T. Kanamori, K. Tsujikawa, Y. Ohmae, Y.T. Iwata, H. Inoue, T. Kishi, T. Nakahama & Y. Inouye. (2005) A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes. Forensic Science International 148:2-3, pages 131-137.
Crossref
Crossref
Justine L. Lam & Leslie Z. Benet. (2004) HEPATIC MICROSOME STUDIES ARE INSUFFICIENT TO CHARACTERIZE IN VIVO HEPATIC METABOLIC CLEARANCE AND METABOLIC DRUG-DRUG INTERACTIONS: STUDIES OF DIGOXIN METABOLISM IN PRIMARY RAT HEPATOCYTES VERSUS MICROSOMES. Drug Metabolism and Disposition 32:11, pages 1311-1316.
Crossref
Crossref
Nadège Blanchard, Lysiane Richert, Brigitte Notter, Frederic Delobel, Pascale David, Philippe Coassolo & Thierry Lavé. (2004) Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes. European Journal of Pharmaceutical Sciences 23:2, pages 189-199.
Crossref
Crossref
Nicola J HewittDietmar Utesch. (2016) Cryopreserved rat, dog and monkey hepatocytes: measurement of drug metabolizing enzymes in suspensions and cultures. Human & Experimental Toxicology 23:6, pages 307-316.
Crossref
Crossref
Greetje Elaut, Gabriëlla TörökPeggy Papeleu, Tamara Vanhaecke, Georges Laus, Dirk Tourwé & Vera Rogiers. (2019)
Rat Hepatocyte Suspensions as a Suitable
In Vitro
Model for Studying the Biotransformation of Histone Deacetylase Inhibitors
. Alternatives to Laboratory Animals 32:1_suppl, pages 105-112.
Crossref
Crossref
Esther F.A Brandon, Christiaan D Raap, Irma Meijerman, Jos H Beijnen & Jan H.M Schellens. (2003) An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicology and Applied Pharmacology 189:3, pages 233-246.
Crossref
Crossref
Yoichi Naritomi, Shigeyuki Terashita, Akira Kagayama & Yuichi Sugiyama. (2003) Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro. Drug Metabolism and Disposition 31:5, pages 580-588.
Crossref
Crossref
N. Le Goff, J. C. Koffel, S. Vandenschrieck, L. Jung & G. Ubeaud. (2002) Comparison of in vitro hepatic models for the prediction of metabolic interaction between simvastatin and naringenin. European Journal of Drug Metabolism and Pharmacokinetics 27:4, pages 233-241.
Crossref
Crossref
Katrin Zeilinger, Igor M. Sauer, Gesine Pless, Catrin Strobel, Jeannette Rudzitis, Aiguo Wang, Andres K. Nüssler, Alexander Grebe, Lei Mao, Stefan H.G. Auth, Juliane Unger, Peter Neuhaus & Jörg C. Gerlach. (2002)
Three-dimensional Co-culture of Primary Human Liver Cells in Bioreactors for
In Vitro
Drug Studies: Effects of the Initial Cell Quality on the Long-term Maintenance of Hepatocyte-specific Functions
. Alternatives to Laboratory Animals 30:5, pages 525-538.
Crossref
Crossref
T. Lavé, O. Luttringer, J. Zuegge, G. Schneider, P. Coassolo & F.-P. Theil. 2002. Pharmacokinetic Challenges in Drug Discovery. Pharmacokinetic Challenges in Drug Discovery
81
104
.
Margherita Strolin Benedetti. (2001) Biotransformation of xenobiotics by amine oxidases. Fundamental & Clinical Pharmacology 15:2, pages 75-84.
Crossref
Crossref
Genevieve Ubeaud, Claus-Ditter Schiller, Fabrice Hurbin, Daniel Jaeck & Philippe Coassolo. (2001) Comparison of the stability of some major cytochrome P450 and conjugation reactions in rat, dog and human hepatocyte monolayers. European Journal of Drug Metabolism and Pharmacokinetics 26:1-2, pages 37-45.
Crossref
Crossref
Jochen Zuegge, Gisbert Schneider, Philippe Coassolo & Thierry Lav??. (2001) Prediction of Hepatic Metabolic Clearance. Clinical Pharmacokinetics 40:7, pages 553-563.
Crossref
Crossref
Martin K. Bayliss & David M. Cross. 2000. The Hepatocyte Review. The Hepatocyte Review
365
389
.